Rapport Therapeutics, Inc. RAPP Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Product | ||||||
| Other Costs | $7.07M+88.7% | $6.68M+137% | $5.63M+130% | $4.75M+135% | $3.75M+109% | |
| Preclinical Programs External Expenses | $17.61M+11.1% | $16.57M+0.2% | $15.68M+5.3% | $14.92M+17.0% | $15.85M+82.5% | |
| RAP219Program External Expenses | $49M+87.4% | $41.14M+86.3% | $34.13M+102% | $30.98M+124% | $26.14M+126% | |
| Research And Development Personnel Related Costs Including Stock-Based Compensation | $34.26M+53.8% | $30.4M+55.9% | $26.3M+59.2% | $24.35M+79.3% | $22.27M+94.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Rapport Therapeutics, Inc. break its business down?
- Rapport Therapeutics, Inc. (RAPP) reports selling general and administrative expense by product across 3 parts — Facility Related And Other, General And Administrative Personnel Related Costs Including Stock-Based Compensation and Professional And Consulting Costs. Each is extracted from the segment footnotes and tracked over time.
- Where does Rapport Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Rapport Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.